A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease
Clinical trial NCT03119662 · TERMINATED
Trial details
- NCT number
- NCT03119662
- Sponsor
- GE Healthcare
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2018-09-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.